Abstract

Background and ImportanceIntravitreal injections of ranibizumab and aflibercept are established initial therapies for managing macular oedema arising from central retinal vein occlusion (CRVO). However, there is a lack of extensive...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call